Loading...
MTAA
SOL
Market cap6.27bUSD
Jun 18, Last price  
60.30EUR
1D
0.00%
1Q
18.00%
Jan 2017
656.59%
Name

SOL SpA

Chart & Performance

D1W1MN
MTAA:SOL chart
P/E
37.03
P/S
3.40
EPS
1.63
Div Yield, %
0.65%
Shrs. gr., 5y
Rev. gr., 5y
12.23%
Revenues
1.78b
+10.29%
403,555,000442,411,000472,470,000462,621,000534,041,000559,858,000582,968,000596,322,000636,360,000674,216,000703,370,000756,807,000833,513,000904,313,000973,833,0001,112,909,0001,379,187,0001,487,136,0001,610,444,0001,776,086,000
Net income
167m
+13.06%
17,682,00027,878,00035,988,00026,102,00032,827,00031,146,00029,027,00021,629,00029,181,00032,441,00044,125,00040,239,00051,880,00049,338,000103,047,00089,549,000133,693,000145,733,000147,698,000166,993,000
CFO
277m
-6.96%
41,096,00071,149,00065,486,00080,414,00062,075,00085,928,00087,414,00099,752,000124,512,00092,696,000117,962,000136,707,000132,609,000186,385,000199,351,000192,564,000214,919,000270,060,000297,490,000276,774,000
Dividend
May 19, 20250.39 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

SOL S.p.A., a global enterprise established in Monza, Italy, in 1927, operates as a subsidiary of Gas and Technologies World BV. The company primarily focuses on the research, manufacturing, and distribution of a diverse array of technical and medical gases, while simultaneously delivering comprehensive home healthcare solutions and associated medical equipment. Its extensive gas portfolio includes vital elements such as oxygen, nitrogen, and argon, alongside specialized gas mixtures, high-purity gases for the electronics industry, and food-grade gases. These products are supplied to various sectors including chemical, electronics, steel, metal, and food processing, as well as supporting environmental protection, scientific research, and healthcare. In the realm of home healthcare, SOL provides critical in-home therapies like oxygen, mechanical ventilation, and aerosol treatments. It also specializes in the diagnosis and management of respiratory sleep disorders, offers artificial nutrition programs, insulin pump therapy, immunotherapy, and dedicated support for pain and Parkinson's disease. Further extending its healthcare reach, the company delivers general home health and social care services, augmented by telemedicine platforms, digital health tools, and a range of healthcare aids. Beyond these core gas and home healthcare operations, SOL S.p.A. engages in a variety of complementary ventures. These encompass the design, construction, and management of biobanks; the generation and sale of hydroelectric power; and the provision of pre- and post-natal diagnostic screening. The company also develops and markets diagnostic systems and products for research and clinical applications across hospital, environmental, veterinary, and food sectors, alongside specialized bioshipping services for the secure transfer, storage, and handling of biological samples. Additional services include professional training, electromedical equipment support, hospital hygiene, environmental monitoring, and ambulance management, all facilitated by its proprietary InfoHealth SOLution web platform for operational oversight.
IPO date
Jul 01, 1998
Employees
Domiciled in
IT
Incorporated in
IT

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT